Victory Capital Management Inc Atreca, Inc. Transaction History

Victory Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$2.87 - $6.29 $67,531 - $148,003	-23,530 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$4.91 - $9.07 $436 - $807	-89 Reduced 0.38%	23,530 $147,000
Q2 2021 Aug 03, 2021	SELL	$7.82 - $13.8 $8,891 - $15,690	-1,137 Reduced 4.59%	23,619 $201,000
Q1 2021 May 04, 2021	SELL	$13.0 - $19.34 $1.66 Million - $2.47 Million	-127,872 Reduced 83.78%	24,756 $380,000
Q4 2020 Feb 01, 2021	SELL	$13.03 - $17.09 $297,657 - $390,403	-22,844 Reduced 13.02%	152,628 $2.47 Million
Q3 2020 Nov 09, 2020	BUY	$12.67 - $23.19 $1.27 Million - $2.33 Million	100,501 Added 134.05%	175,472 $2.45 Million
Q2 2020 Aug 07, 2020	SELL	$12.52 - $23.45 $2.64 Million - $4.94 Million	-210,667 Reduced 73.75%	74,971 $1.6 Million
Q1 2020 May 04, 2020	SELL	$11.4 - $27.28 $103,021 - $246,529	-9,037 Reduced 3.07%	285,638 $4.73 Million
Q4 2019 Feb 06, 2020	BUY	$9.68 - $18.67 $3,988 - $7,692	412 Added 0.14%	294,675 $4.56 Million
Q4 2019 Feb 04, 2020	SELL	$9.68 - $18.67 $105,018 - $202,550	-10,849 Reduced 3.56%	294,263 $5.41 Million
Q3 2019 Nov 12, 2019	BUY	$10.42 - $22.04 $2.17 Million - $4.58 Million	208,000 Added 214.19%	305,112 $3.74 Million
Q2 2019 Aug 15, 2019	BUY	$17.07 - $18.84 $1.66 Million - $1.83 Million	97,112 New	97,112 $1.83 Million

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.